Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. | Cancer Res;61(6): 2429-33, 2001 Mar 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.

Chen, E Y; Mazure, N M; Cooper, J A; Giaccia, A J.

Affiliation

Chen EY; Department of Radiation Oncology, Center for Clinical Science Research-South, Stanford, California 94305-5152, USA.

Cancer Res ; 61(6): 2429-33, 2001 Mar 15.

Article in En | MEDLINE | ID: mdl-11289110

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxygen / Signal Transduction / Proto-Oncogene Proteins / Protein Serine-Threonine Kinases / Calcium-Calmodulin-Dependent Protein Kinases / Phosphatidylinositol 3-Kinases / Receptor, Platelet-Derived Growth Factor beta Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2001 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Oxygen / Signal Transduction / Proto-Oncogene Proteins / Protein Serine-Threonine Kinases / Calcium-Calmodulin-Dependent Protein Kinases / Phosphatidylinositol 3-Kinases / Receptor, Platelet-Derived Growth Factor beta Limits: Animals / Humans Language: En Journal: Cancer Res Year: 2001 Document type: Article Affiliation country: Country of publication: